May 13, 2025-- GE HealthCare recently announced the U.S. Food and Drug Administration (FDA) has approved a pediatric indication for the company’s Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) ultrasound enhancing agent (UEA). This approval will help improve the clarity and diagnostic accuracy of echocardiograms in pediatric patients, giving cardiologists a fuller picture of ventricular function when assessing possible heart abnormalities or disease. 

May 19, 2025 - Arineta, a provider of cardiovascular imaging solutions, recently announced that its SpotLight Duo cardiac CT scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for low-dose lung cancer screening (LDCT). This clearance allows providers to use a single ultra-fast CT platform for both cardiac and lung imaging and diagnostics, delivering more complete care to high-risk patients.

May 15, 2025 – Royal Philips, a global leader in health technology, has released its 10th annual Future Health Index (FHI) report, highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery.

May 14, 2025 – Bialogics Analytics Inc., a leader in radiology informatics, has introduced its new AI solution AI Quality Framework (AIQ), a first-of-its-kind, evidence-driven framework for continuous, real-time assessment of AI systems in diagnostic imaging.

May 13, 2025 — In one of the larger studies of its kind, researchers have identified six breast texture patterns that may be associated with increased cancer risk, according to a new study published in Radiology, a journal of the Radiological Society of North America (RSNA).

May 15, 2025 — GE HealthCare has launched CleaRecon DL, technology powered by a deep-learning algorithm, to improve the quality of cone-beam computed tomography (CBCT) images. This artificial intelligence (AI)-driven solution is designed to remove streak artifacts caused by the pulsatile nature of blood flow in the arteries and changes in the distribution of contrast during CBCT acquisitions in liver, prostate, neuro, and endovascular aortic repair procedures. CleaRecon DL recently received U.S.

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and better serve customers in the United States, its largest market globally.

The new investments come on top of the $900 million Siemens Healthineers spends on R&D in the U.S. annually and more than $1 billion invested through facilities expansion, acquisitions and strategic partnerships in the U.S. since 2019.

The latest investments include:

May 14, 2025 — A comprehensive new study based on nationwide claims data from more than 11 million patients shows that diagnostic contrast-enhanced ultrasound (CEUS) exams are safe and can lower a patient’s risk of death.

The study, posted online by the Journal of the American Heart Association, found that serious adverse events associated with ultrasound enhancing agents (UEAs) are “uncommon,” occurring in only 1:10,000 cases.

May 12, 2025 — GE HealthCare recently unveiled Signa Sprint, an FDA 510(k) pending

The issue of sustainability in healthcare has gained increasing focus over the past several years. During a 2022 plenary session at the Radiological Society of North America (RSNA) Annual Conference and Annual Meeting, Reed A.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now